Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.
about
mRNA capping: biological functions and applicationsZika virus protection by a single low-dose nucleoside-modified mRNA vaccinationmRNA vaccine delivery using lipid nanoparticles.Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia.Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge.Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies.State of play and clinical prospects of antibody gene transfer.Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges.Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.mRNA mediates passive vaccination against infectious agents, toxins, and tumors.Nucleoside Modified mRNA Vaccines for Infectious Diseases.Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications.Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques.Structurally Programmed Assembly of Translation Initiation Nanoplex for Superior mRNA Delivery.In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections.Polyamine-Mediated Stoichiometric Assembly of Ribonucleoproteins for Enhanced mRNA Delivery.Design, Assembly, Production, and Transfection of Synthetic Modified mRNA.Safety Evaluation of Lipid Nanoparticle-Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey.Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines.Rapid, Single-Cell Analysis and Discovery of Vectored mRNA Transfection In Vivo with a loxP-Flanked tdTomato Reporter Mouse.Engineering the Delivery System for CRISPR-Based Genome Editing.Pieter Cullis' quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?mRNA vaccines - a new era in vaccinology.Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.Optimizing Cardiac Delivery of Modified mRNA.Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.mRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice.Tools for translation: non-viral materials for therapeutic mRNA deliveryNew Vaccine Technologies to Combat Outbreak SituationsKinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticlesNucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
P2860
Q27469050-E6EA0499-B83A-43B3-995D-F43CC1D0A6A6Q28656365-451010B8-05F4-40A9-BAD8-A5826F3E138CQ33711685-4DD60388-93C4-4C56-8475-D479B8AA7C71Q36588584-86A391F5-DE67-43AE-BAEB-29A84E6882D3Q37607987-85715719-318D-47C7-BF2E-7584C29CD1CDQ37681765-EC194AFC-A588-44C9-ACBB-C88CF651675DQ38641141-C42D35DA-F602-4BEA-8CEA-133D37513267Q38737706-4EE72528-4692-449B-AC00-D6836D35E628Q38850538-2E2A7F20-74A0-4843-811B-9746808E74B7Q39091854-570ECEB4-E522-43D1-9448-617835B6E17CQ40088616-2C01C4C8-7252-47CC-9656-679658142F33Q40405926-2C962BB4-A30E-484F-9749-2CE78793E74EQ41271806-C7477847-04F6-4767-9841-51260B91D33FQ41993335-CB515204-D516-4229-A034-96418CA05B0FQ42276001-9D454E31-DD25-4707-AE2D-CDC14708B700Q42373127-979E6BA9-B056-44FA-AEF7-3FACC1B9A695Q42380133-8B2972BC-7562-4ECD-8B27-7FAC40C6DC19Q45873696-8AE8A709-8861-428E-9578-F1EE6B8CF816Q46250879-0D4E020E-9042-42E1-8015-4F894DC87266Q47142027-D5A29322-EB9C-4360-B6B2-8CD46534BF45Q47151105-A85DC241-9398-4CA9-B644-C4A44577F2B5Q47198006-A1A31281-2272-4F9C-A9D1-4EE4EC18F249Q47607348-0BA85F73-3548-4FFC-B72B-3E3DCE4A531FQ47736893-C60B681C-1DB8-4DFB-BE48-AD114935E206Q50056652-D8B0E931-D118-4A8F-BD1C-309AC7511BB2Q50445673-5D991DA1-6883-4FE5-912D-14A8C57E6249Q52626761-C23C9FC5-5A4C-4E26-9F54-61A474202313Q54217790-94E28EAF-6ACE-4C72-8E50-1985300B966DQ55287154-4A23155F-1E84-4D01-9695-C96E17C0616CQ56057560-D66BC432-29FF-4EC8-8729-988D255C3411Q57072744-7391F49A-EAAF-4C26-8BDC-64C54B894635Q57154802-50E4ACA5-5B19-4AF9-8E79-2670F3D966EFQ58721961-C1D03A69-E09C-4C0F-B7EA-6378DFDD1DA3
P2860
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Expression kinetics of nucleos ...... les to mice by various routes.
@ast
Expression kinetics of nucleos ...... les to mice by various routes.
@en
type
label
Expression kinetics of nucleos ...... les to mice by various routes.
@ast
Expression kinetics of nucleos ...... les to mice by various routes.
@en
prefLabel
Expression kinetics of nucleos ...... les to mice by various routes.
@ast
Expression kinetics of nucleos ...... les to mice by various routes.
@en
P2093
P2860
P1476
Expression kinetics of nucleos ...... les to mice by various routes.
@en
P2093
Barbara L Mui
Drew Weissman
Hiromi Muramatsu
Katalin Kariko
Michael J Hope
Norbert Pardi
Steven Tuyishime
Thomas D Madden
Ying K Tam
P2860
P304
P356
10.1016/J.JCONREL.2015.08.007
P407
P577
2015-08-08T00:00:00Z